Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
USD 0.25
(-0.78%)
USD 0.25
(-0.78%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -6.59 Million USD | -112.71% |
| 2022 | -3.09 Million USD | -157.66% |
| 2021 | -1.2 Million USD | -42.3% |
| 2020 | -845.36 Thousand USD | 0.0% |
| 2018 | -626.13 Thousand USD | -193.14% |
| 2017 | -213.59 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -1.73 Million USD | -5.52% |
| 2024 Q2 | -2.03 Million USD | -17.34% |
| 2023 Q2 | -2.18 Million USD | -864.54% |
| 2023 Q1 | 285.71 Thousand USD | 134.76% |
| 2023 Q4 | -1.64 Million USD | 8.49% |
| 2023 Q3 | -1.79 Million USD | 17.93% |
| 2023 FY | -6.59 Million USD | -112.71% |
| 2022 Q3 | -1.01 Million USD | -21.05% |
| 2022 Q2 | -840.92 Thousand USD | -15.94% |
| 2022 Q1 | -725.28 Thousand USD | -58.0% |
| 2022 FY | -3.09 Million USD | -157.66% |
| 2022 Q4 | -821.91 Thousand USD | 19.25% |
| 2021 Q1 | -129.32 Thousand USD | 0.0% |
| 2021 FY | -1.2 Million USD | -42.3% |
| 2021 Q4 | -459.04 Thousand USD | -111.58% |
| 2021 Q3 | -216.96 Thousand USD | 37.44% |
| 2021 Q2 | -346.8 Thousand USD | -168.16% |
| 2020 FY | -845.36 Thousand USD | 0.0% |
| 2018 FY | -626.13 Thousand USD | -193.14% |
| 2017 FY | -213.59 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 113.691% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -112.769% |
| Embecta Corp. | 70.4 Million USD | 109.365% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 115.714% |
| PainReform Ltd. | -9.34 Million USD | 29.444% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -46.308% |
| SCYNEXIS, Inc. | 67.04 Million USD | 109.834% |
| Journey Medical Corporation | -3.85 Million USD | -71.106% |
| Safety Shot Inc | -15.08 Million USD | 56.29% |
| Alpha Teknova, Inc. | -36.78 Million USD | 82.075% |
| Bright Green Corporation | -13.12 Million USD | 49.78% |
| Procaps Group, S.A. | 42.54 Million USD | 115.498% |
| Alvotech | -551.73 Million USD | 98.805% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 135.107% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | 16.23% |
| Cosmos Health Inc. | -18.54 Million USD | 64.446% |
| Dynavax Technologies Corporation | -6.38 Million USD | -3.189% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 96.849% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 95.28% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -46.308% |
| Theratechnologies Inc. | -23.95 Million USD | 72.481% |
| Harrow Health, Inc. | -24.41 Million USD | 72.993% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -36.354% |
| Biofrontera Inc. | -20.13 Million USD | 67.251% |
| DURECT Corporation | -27.62 Million USD | 76.134% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 600.967% |
| Cronos Group Inc. | -73.96 Million USD | 91.086% |
| OptiNose, Inc. | -35.48 Million USD | 81.42% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 99.342% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 84.377% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 127.566% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 233.321% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 4271.738% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -4.991% |
| Radius Health, Inc. | -25.79 Million USD | 74.438% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -6.972% |
| ProPhase Labs, Inc. | -16.78 Million USD | 60.716% |
| Phibro Animal Health Corporation | 2.41 Million USD | 372.878% |
| Procaps Group S.A. | 42.54 Million USD | 115.498% |
| TherapeuticsMD, Inc. | -10.27 Million USD | 35.856% |
| Viatris Inc. | 54.7 Million USD | 112.053% |
| Rockwell Medical, Inc. | -8.43 Million USD | 21.878% |
| Aytu BioPharma, Inc. | -15.84 Million USD | 58.39% |
| SIGA Technologies, Inc. | 68.06 Million USD | 109.685% |
| Tilray Brands, Inc. | -244.98 Million USD | 97.309% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 154.88% |
| Shineco, Inc. | -22.44 Million USD | 70.632% |
| PetIQ, Inc. | 2.13 Million USD | 409.372% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -53.254% |
| Incannex Healthcare Limited | -18.45 Million USD | 64.285% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 102.64% |
| Alimera Sciences, Inc. | -20.13 Million USD | 67.253% |
| Silver Spike Investment Corp. | 7.34 Million USD | 189.818% |
| Assertio Holdings, Inc. | -331.94 Million USD | 98.014% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | 19.238% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | 63.167% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 67.131% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 95.887% |
| Hempacco Co., Inc. | -13.12 Million USD | 49.774% |
| Talphera, Inc. | -18.39 Million USD | 64.164% |
| Alvotech | -551.73 Million USD | 98.805% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 118.497% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 102.018% |
| Currenc Group, Inc. | -15.3 Million USD | 56.929% |
| Kamada Ltd. | 8.28 Million USD | 179.584% |
| Indivior PLC | 2 Million USD | 429.636% |
| Evoke Pharma, Inc. | -7.79 Million USD | 15.394% |
| Flora Growth Corp. | -57.03 Million USD | 88.441% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 67.131% |
| Evolus, Inc. | -61.68 Million USD | 89.312% |
| HUTCHMED (China) Limited | 100.78 Million USD | 106.542% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 104.793% |
| Akanda Corp. | -32.27 Million USD | 79.573% |